In agreement with these previous findings, our data demonstrate that ACE2 null mice show a significant decrease in UCP2 mRNA levels in aorta which may directly contribute to the increase in •O2- and decreased •NO bioavailability and, consequently, to endothelial dysfunction. The gene discussed is ACE2; the disease is endothelial dysfunction.